HomeMost PopularInvestingNu Skin (NUS) Q1 Earnings Beat, Revenues Hurt by Currency Woes

Nu Skin (NUS) Q1 Earnings Beat, Revenues Hurt by Currency Woes

Actionable Trade Ideas

always free

Nu Skin Enterprises, Inc. NUS posted first-quarter 2024 results, wherein both the top and bottom lines declined year over year, and revenues missed the Zacks Consensus Estimate. Foreign currency headwinds had a greater-than-anticipated impact on revenues. However, the company’s diligent cost management efforts aided its bottom-line performance.

Nu Skin is actively pursuing business transformation initiatives and advancing its integrated beauty, wellness and lifestyle ecosystem. While macroeconomic challenges hurt the affiliate and customer growth globally in the Nu Skin core business, the company saw notable gains in the Rhyz business. Key product launches such as ageLOC WellSpa iO, RenuSpa iO, and TRMe also performed well.

Amid the ongoing business transformation challenges in the current disruptive landscape, Nu Skin remains steadfast in evolving strategies for both Nu Skin and Rhyz businesses, prioritizing long-term growth and delivering shareholder value.

Quarter in Detail

Nu Skin posted adjusted earnings of 9 cents a share, excluding restructuring. The metric declined from the adjusted figure of 37 cents reported in the year-ago quarter. However, the bottom line surpassed the Zacks Consensus Estimate of 5 cents.

Nu Skin Enterprises, Inc. Price, Consensus and EPS Surprise

Nu Skin Enterprises, Inc. Price, Consensus and EPS Surprise

Nu Skin Enterprises, Inc. price-consensus-eps-surprise-chart | Nu Skin Enterprises, Inc. Quote

Revenues of $417.3 million tumbled 13.3% year over year. Revenues included a negative impact of 3.8% from foreign currency fluctuations. On a constant currency basis, revenues fell 9.5%. Rhyz revenues grew substantially by about 60% year over year. Nu Skin’s top line fell short of the Zacks Consensus Estimate of $431 million.

Sales leaders were down 12% year over year to 38,609. Nu Skin’s customer base dropped 19% to 875,261. The company’s paid affiliates were down 30% to 154,171. On an adjusted basis, paid affiliates tumbled 14%.

The gross profit of $294.1 million declined from the $347.9 million reported in the year-ago quarter. The gross margin came in at 70.5%, down from the 72.3% reported in the year-ago quarter. The Nu Skin business’ gross margin came in at 76.9%, up from the 76.4% reported in the year-ago quarter.

Selling expenses declined to $153.5 million from the $188.1 million reported in the prior-year quarter. As a percentage of revenues, the metric was 36.8%, down from the 39.1% reported in the year-ago quarter. Nu Skin business’ selling expenses were 41.7%, in line with the prior-year quarter.

General and administrative expenses of $124.6 million decreased from $133.9 million in the year-ago quarter. As a percentage of revenues, general and administrative expenses were 29.9%, up from 27.8% in the year-ago period.

The company’s adjusted operating margin (excluding restructuring charges) contracted 160 basis points to 3.8%.

Regional Results

Region-wise, revenues (at cc) declined 20.1%, 6.1%, 8.1%, 5.6%, 11.8%, 39.3% and 9.8% in the Americas, Mainland China, Southeast Asia/Pacific, Japan, Europe & Africa, South Korea and Hong Kong/Taiwan, respectively. Meanwhile, Nu Skin’s other revenues surged 684.3% year over year.

Other Financial Details

Nu Skin ended the quarter with cash and cash equivalents of $212.5 million, long-term debt of $453.2 million and total stockholders’ equity of $810.2 million. In the reported quarter, the company paid out dividends of $3 million while not making any share repurchases. NUS has $162.4 million remaining under the current share repurchase authorization.


Nu Skin remains focused on undertaking strategic measures to optimize its cost structure in alignment with business performance. It also continues to prioritize revenue-driving initiatives, margin amplification and financial security. While adverse foreign currency effects were more pronounced than initially anticipated and are expected to persist, Nu Skin reiterated its 2024 revenue and adjusted EPS guidance.

Nu Skin anticipates revenues in the band of $1.73-$1.87 billion for 2024, which suggests a 12-5% decline from the year-ago period’s reported figure. The company envisions unfavorable foreign currency impacts of 3-2% on 2024 revenues.

Management envisions an adjusted EPS of 95 cents to $1.35. The projection suggests a decline from adjusted earnings of $1.85 recorded in 2023. On a reported basis, management anticipates earnings in the range of 77 cents-$1.16 per share compared with 17 cents delivered in 2023.

For the second quarter of 2024, Nu Skin expects revenues between $420 million and $455 million, including an unfavorable foreign currency impact of nearly 4% to 3%. The revenue projection suggests a decline of 16% to 9% from the year-ago quarter’s reported level. The company expects adjusted earnings of 10-20 cents a share. On a reported basis, NUS expects earnings between 1 and 10 cents per share for the second quarter.

Shares of this Zacks Rank #3 (Hold) company have declined 29.4% in the past three months compared with the industry’s decrease of 10.4%.

Better-Ranked Staple Bets

Here, we have highlighted three better-ranked stocks, namely Tyson Foods, Inc. TSN, Hormel Foods HRL and Beyond Meat (BYND).

Tyson Foods, which operates through Beef, Pork, Chicken and Prepared Foods segments, currently sports a Zacks Rank #1 (Strong Buy). TSN delivered a positive earnings surprise of 24.4% in the trailing four quarters, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for Tyson Foods’ current fiscal-year earnings calls for growth of 76.1% from the year-ago reported numbers.

Hormel Foods develops, processes and distributes various meat, nuts and other food products. It currently carries a Zacks Rank #2 (Buy). HRL has a trailing four-quarter earnings surprise of 3.5%, on average.

The Zacks Consensus Estimate for Hormel Foods’ current financial-year sales suggests growth of 1.2% from the year-ago reported number.

Beyond Meat, which develops, manufactures, markets and sells plant-based meat products, currently carries a Zacks Rank #2. The Zacks Consensus Estimate for BYND’s current fiscal year bottom line has improved from a loss of $2.46 to a loss of $2.29 in the past 30 days.

The Zacks Consensus Estimate for Beyond Meat’s current financial-year earnings implies growth of 39.4% from the year-ago reported number.

Zacks Names “Single Best Pick to Double”

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s an American AI company that’s riding low right now, but it has rounded up clients like BMW, GE, Dell Computer, and Bosch. It has prospects for not just doubling but quadrupling in the year to come. Of course, all our picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Hormel Foods Corporation (HRL) : Free Stock Analysis Report

Tyson Foods, Inc. (TSN) : Free Stock Analysis Report

Nu Skin Enterprises, Inc. (NUS) : Free Stock Analysis Report

Beyond Meat, Inc. (BYND) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.